Home > Insider Trading > Filing (0000899243-16-021418)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1358762	Reata Pharmaceuticals Inc	RETA	Pharmaceutical Preparations (2834)	113651945

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1662321	Edward James Bass	2801 Gateway Drive, Suite 150 Irving TX 75063		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2016-06-01	5,000	$13.28	5,000	No	4	P	Direct
Class A Common Stock	Acquisiton	2016-06-01	2,585	$0.00	7,585	No	4	C	Direct
Class A Common Stock	Acquisiton	2016-06-01	18,000	$11.00	25,585	No	4	P	Direct
Class A Common Stock	Acquisiton	2016-06-01	3,455	$0.00	3,455	No	4	C	Indirect	By Bass Family Trust A
Class A Common Stock	Acquisiton	2016-06-01	1,448	$0.00	1,448	No	4	C	Indirect	By Bass Trust FBO James E. Bass

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	C	Direct
No	4	P	Direct
No	4	C	Indirect	By Bass Family Trust A
No	4	C	Indirect	By Bass Trust FBO James E. Bass

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Class B common stock	Disposition	2016-06-01	2,585	$0.00	2,585	$0.00
Class A Common Stock	Class B common stock	Disposition	2016-06-01	3,455	$0.00	3,455	$0.00
Class A Common Stock	Class B common stock	Disposition	2016-06-01	1,448	$0.00	1,448	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
28,762	No	4	C	Direct
38,447	No	4	C	Indirect
16,107	No	4	C	Indirect

Footnotes

The Class B common stock is convertible into Class A common stock on a one-for-one basis (a) at the holder's election at any time after the date that is six months following the date of the closing of the initial public offering of the company's Class A common stock, (b) at the holder's election prior to that time subject to certain conditions, or (c) at the option of the company's board of directors, in its sole discretion, at any time or multiple times from time to time on or before the closing of the initial public offering. The conversion right of the Class B common stock has no expiration date.
Due to the conditions to closing of the initial public offering of the Class A common stock, these purchases were not deemed to occur until closing, on June 1, 2016.